You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
啓明醫療(02500.HK)收購以色列醫療器械商餘下94.8%股權
阿思達克 12-08 08:37
啓明醫療(02500.HK)公佈,收購以色列從事醫療器械研發活動的Mitraltech(目標公司)餘下的94.8%股權,代價包括總交割代價1.5億美元,及獲利計酬期間實現若幹裏程碑的情況下支付不逾1.16億美元。完成後,公司持有Mitraltech全部股權。 同時,公司的全資附屬啓明香港,向目標公司的全資附屬Cardiovalve提供2,300萬美元可換股貸款,年利率3%,到期日爲2024年12月9日。 Cardiovalve擁有40名員工,在設有內部生產及潔淨室的1,700平方尺設施運營,並持有200多項專利及專利申請,其獨立開發的Cardiovalve系統是一種經導管介入置換產品,適用於患有二尖瓣或三尖瓣反流的患者。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account